13F Data
13F filer · CIK 1444043

Camber Capital Management LP

BOSTON, MA · filing since Q2 2013 · last filing Aug 14, 2025
Reported value
$1.1B
$-1.7B vs prior
Positions
25
New / sold out
4 / 11
Added / reduced
1 / 17
Turnover
6.9%
buys $134.6M · sells $1.9B
Top-10 weight
79.2%

Biggest buys vs Q1 2025

ChangeSecurityShares changeChange %Est. trade value
NewICON PLC+300,000–+$43.6M
NewMERCK & CO INC+500,000–+$39.6M
NewUNITEDHEALTH GROUP INC+100,000–+$31.2M
NewAPELLIS PHARMACEUTICALS INC+850,000–+$14.7M
AddedBIOMARIN PHARMACEUTICAL INC+100,000+20.0%+$5.5M

Biggest sells vs Q1 2025

ChangeSecurityShares changeChange %Est. trade value
ReducedSPYSPDR S&P 500 ETF TRPUT-1,000,000-66.7%$-617.9M
Sold outPFIZER INCCALL-6,800,000-100.0%$-172.3M
Sold outSPDR SER TRPUT-2,000,000-100.0%$-162.2M
ReducedZIMMER BIOMET HOLDINGS INC-1,250,000-55.6%$-114.0M
ReducedHUMANA INC-425,000-58.6%$-103.9M
ReducedBAXTER INTL INC-2,900,000-50.4%$-87.8M
ReducedCVSCVS HEALTH CORP-1,200,000-53.3%$-82.8M
Sold outPTC THERAPEUTICS INC-1,500,000-100.0%$-76.4M
Sold outTHE CIGNA GROUP-200,000-100.0%$-65.8M
Sold outQIAGEN NV-1,400,000-100.0%$-56.2M
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $972.2MQ3 2013: $954.0MQ4 2013: $1.1BQ1 2014: $1.3BQ2 2014: $1.5BQ3 2014: $1.1BQ4 2014: $1.5BQ1 2015: $1.4BQ2 2015: $1.5BQ3 2015: $1.2BQ4 2015: $1.5BQ1 2016: $1.7BQ2 2016: $2.1BQ3 2016: $2.3BQ4 2016: $1.9BQ1 2017: $2.5BQ2 2017: $2.1BQ3 2017: $1.6BQ4 2017: $2.0BQ1 2018: $2.0BQ2 2018: $2.6BQ3 2018: $2.3BQ4 2018: $2.1BQ1 2019: $2.0BQ2 2019: $2.1BQ3 2019: $1.9BQ4 2019: $2.0BQ1 2020: $1.7BQ2 2020: $1.7BQ3 2020: $1.9BQ4 2020: $2.8BQ1 2021: $2.9BQ2 2021: $3.0BQ3 2021: $3.2BQ4 2021: $2.9BQ1 2022: $2.8BQ2 2022: $2.3BQ3 2022: $3.3BQ4 2022: $2.9BQ1 2023: $3.3BQ2 2023: $3.1BQ3 2023: $3.0BQ4 2023: $3.9BQ1 2024: $4.1BQ2 2024: $3.6BQ3 2024: $3.1BQ4 2024: $4.3BQ1 2025: $2.8BQ2 2025: $1.1B
Q2 2013Q2 2025

Holdings · Q2 2025

#SecuritySharesValueWeight
1SPYSPDR S&P 500 ETF TRPUT500,000$308.9M29.00%
2ZIMMER BIOMET HOLDINGS INCCOM1,000,000$91.2M8.56%
3BAXTER INTL INCCOM2,850,000$86.3M8.10%
4HUMANA INCCOM300,000$73.3M6.89%
5CVSCVS HEALTH CORP1,050,000$72.4M6.80%
6GLOBUS MED INCCL A800,000$47.2M4.43%
7ICON PLCSHS300,000$43.6M4.10%
8ASCENDIS PHARMA A/SSPONSORED ADR250,000$43.1M4.05%
9MERCK & CO INCCOM500,000$39.6M3.72%
10GSK PLCCALLSPONSORED ADR1,000,000$38.4M3.60%
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.